Manchester researchers develop gene therapy for rare condition, offering hope to children

A three-year-old boy received a world-first gene therapy treatment in Manchester for a rare genetic condition, offering hope to others. The revolutionary stem cell therapy, developed over a decade, aims to correct the faulty gene responsible for Hunter Syndrome, potentially eliminating the need for lifelong infusions. Oliver Chu, from the US, is the first of five children to undergo the procedure at Royal Manchester Children's Hospital, showing promising recovery and improved health.